Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Berna, MJ; Hoffmann, KM; Tapia, JA; Thill, M; Pace, A; Mantey, SA; Jensen, RT.
CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways.
Biochim Biophys Acta. 2007; 1773(4): 483-501.
Doi: 10.1016/j.bbamcr.2006.12.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Hoffmann Karl Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Protein kinase D1 (PKD1) is involved in cellular processes including protein secretion, proliferation and apoptosis. Studies suggest PKD1 is activated by various stimulants including gastrointestinal (GI) hormones/neurotransmitters and growth factors in a protein kinase C (PKC)-dependent pathway. However, little is known about the mechanisms of PKD1 activation in physiologic GI tissues. We explored PKD1 activation by GI hormones/neurotransmitters and growth factors and the mediators involved in rat pancreatic acini. Only hormones/neurotransmitters activating phospholipase C caused PKD1 phosphorylation (S916, S744/748). CCK activated PKD1 and caused a time- and dose-dependent increase in serine phosphorylation by activation of high- and low-affinity CCK(A) receptor states. Inhibition of CCK-stimulated increases in phospholipase C, PKC activity or intracellular calcium decreased PKD1 S916 phosphorylation by 56%, 62% and 96%, respectively. PKC inhibitors GF109203X/Go6976/Go6983/PKC-zeta pseudosubstrate caused a 62/43/49/0% inhibition of PKD1 S916 phosphorylation and an 87/13/82/0% inhibition of PKD1 S744/748 phosphorylation. Expression of dominant negative PKC-delta, but not PKC-epsilon, or treatment with PKC-delta translocation inhibitor caused marked inhibition of PKD phosphorylation. Inhibition of Src/PI3K/MAPK/tyrosine phosphorylation had no effect. In unstimulated cells, PKD1 was mostly located in the cytoplasm. CCK stimulated translocation of total and phosphorylated PKD1 to the membrane. These results demonstrate that CCK(A) receptor activation leads to PKD activation by signaling through PKC-dependent and PKC-independent pathways.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Bombesin - pharmacology
- Calcium - deficiency
- Carbachol - pharmacology
- Cholecystokinin - pharmacology
- Dose-Response Relationship, Drug - pharmacology
- Enzyme Activation - drug effects
- Growth Substances - pharmacology
- Isoenzymes - antagonists and inhibitors
- Male - antagonists and inhibitors
- Mitogen-Activated Protein Kinases - metabolism
- Pancreas, Exocrine - cytology
- Phospholipase C - metabolism
- Phosphoserine - metabolism
- Phosphotyrosine - metabolism
- Protein Kinase C-delta - antagonists and inhibitors
- Protein Kinase Inhibitors - pharmacology
- Protein Kinases - metabolism
- Rats - metabolism
- Rats, Sprague-Dawley - metabolism
- Receptors, Cholecystokinin - metabolism
- Signal Transduction - drug effects
- Tetradecanoylphorbol Acetate - pharmacology
- Time Factors - pharmacology
- Find related publications in this database (Keywords)
- PKD1 activation
- pancreas
- cholecystokinin
- gastrointestinal hormone
- growth factor
- PKC